Search

Background: Keratoacanthomas (KAs) following laser treatment are a rare, but well‐described entity. Aim: Herein, we describe a case of eruptive keratoacanthoma (KA) following laser resurfacing treatment and aim to better characterize laser‐associated KAs. Methods: A literature search was performed on PubMed reviewing laser‐associated KAs including various characteristics: epidemiology, history of skin cancer, location, and number, type of laser, as well as the management and outcome. Results: Fractional ablative was the most common type of laser triggering KAs, and most cases presented within the first month following treatment. The majority of cases of laser‐induced KA had a prior history of a malignant or premalignant skin neoplasm. Laser‐induced KAs were treated using modalities similar to KAs arising in other contexts. Conclusion: Clinicians need to be knowledgeable and prepared to understand, and manage complications following laser treatments, as rare as they may be, including KAs. [ABSTRACT FROM AUTHOR]

Background: Several elements, including age, influence judgments of beauty and attractiveness. Aging is affected by intrinsic factors (e.g., genetics, race/ethnicity, anatomical variations) and extrinsic factors (e.g., lifestyle, environment). Aims: To provide a general overview of minimally invasive injectable procedures for facial beautification and rejuvenation to meet the aesthetic goals of patients across their lifespan, organized by decade. Methods: This case study review describes aesthetic considerations of females in their third to sixth decade of life (i.e., 20–60 years of age or beyond). Each case study reports the treatments, specifically botulinum toxin type A and soft tissue fillers, used to address aesthetic concerns. Results: Signs of aging, as well as aesthetic goals and motivations, vary by age groups, cultures, and races/ethnicities. However, there are overarching themes that are associated with each decade of life, such as changes in overall facial shape and specific facial regions, which can be used as a starting point for aesthetic treatment planning. Appropriate patient selection, thorough aesthetic evaluation, product knowledge, and injection technique, as well as good physician‐patient communication, are essential for optimal treatment outcomes. Conclusions: Nonsurgical facial injectable treatments can successfully enhance and rejuvenate facial features across different age ranges. A comprehensive understanding of facial aging and the aesthetic considerations of patients by the decade contributes to optimal treatment planning and maintenance. [ABSTRACT FROM AUTHOR]

Background: The popularity of social media appears to be increasing the acceptance of cosmetic treatments, prompting more consumers to seek cosmetic treatments. As the estimated prevalence of acne vulgaris among adult women may be as high as 54%, acne is commonly observed among patients presenting for cosmetic treatments. Concomitant treatment of acne in the aesthetic patient population will improve overall clinical outcomes. Aims: The goal of this work was to deliver a high‐quality ethical and evidence‐based educational program to physicians and adjunctive health care providers to advance patient care. Methods: This paper is based on a webcam presentation with roundtable discussion by several notable experts in their field. Results: A range of topical medications, injectable products, chemical peels, and energy‐based devices are available for treating acne vulgaris. In most instances, these are compatible with rejuvenation procedures in the aesthetic patient. Conclusion: The growth of social media is raising awareness of aesthetic procedures and appears to be increasing the number of patients seeking aesthetic treatment. Educating patients about the importance of treating acne vulgaris can improve overall treatment outcomes. In most instances, the presence of acne is not a barrier to aesthetic care. [ABSTRACT FROM AUTHOR]

While broad reviews on laser-assisted drug delivery (LADD) have been published in the past, an updated focused examination of its utility in the context of common, treatment-resistant, dermatologic conditions has not been published. We conducted a comprehensive scoping review of the potential benefits of LADD compared to laser or drug monotherapy for the treatment of 3 such conditions: scars, rhytids, and melasma. A PubMed (National Institutes of Health, Bethesda, MD) search was conducted using keywords including "laser-assisted drug delivery", "scar", "rhytid", and "melasma". Out-of-scope studies were excluded. To evaluate the efficacy of LADD for the treatment of scars, we categorized relevant articles by scar type; hypertrophic/keloid, atrophic, and hypopigmented. LADD, with both ablative and non-ablative laser types, was studied in combination with corticosteroids, Botulinum Toxin-A (BTX-A), 5-Fluorouracil (5-FU), 5-Aminolevulinic acid (ALA) photodynamic therapy (PDT), stem-cells, Platelet-rich plasma (PRP), and prostaglandin analogs for the treatment of scars. Some randomized controlled trials demonstrated efficacy with LADD, while others showed no significant differences in clinical outcomes, but demonstrated reduced adverse effects. Regarding rhytids, laser has been combined with varying cosmeceuticals, Polylactic acid (PLLA), topical retinaldehyde, and topical BTX-A. The studies reviewed supported the use of LADD with these drugs compared to monotherapy. Some studies showed that LADD was effective for the absorption of drugs like PLLA and BTX-A which are often not effective topically. For melasma treatment, LADD with tranexamic acid and hydroquinone was superior in some studies, but not significantly different than monotherapy in other studies. LADD with certain drugs could be considered to treat scars, rhytids, and melasma. [ABSTRACT FROM AUTHOR]